腫瘍焼灼療法の市場規模、シェア、成長分析、技術別、治療別、用途別、エンドユーザー別、地域別 - 産業予測 2025-2032年

腫瘍焼灼療法市場規模は2023年に19億米ドルと評価され、2024年の21億7,000万米ドルから2032年には62億8,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは14.2％で成長する見通しです。

がん罹患率の世界の上昇と低侵襲治療アプローチへの嗜好の高まりが、今後数年間における腫瘍焼灼療法技術の需要を牽引する見通しです。アブレーション技術の革新は、プロバイダーにとって新たなビジネスチャンスとなることが期待されます。外来での腫瘍焼灼療法手技の採用が増加しており、併用療法の人気も高まっていることから、製品の売上は大幅に増加すると思われます。さらに、新規のがん治療に対するニーズの高まりや腫瘍学研究への投資の活発化により、ビジネスの可能性はさらに拡大するものと思われます。新興市場、特にがん罹患率の上昇に直面している低・中所得国には大きなビジネスチャンスがあります。しかし、機器の高コスト、従来の治療法との競合、新興国市場での認知度の低さといった課題は、長期的な市場開発の妨げとなる可能性があります。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

腫瘍焼灼療法市場規模：技術別& CAGR（2025-2032）

• 市場概要
• 無線周波数
• マイクロ波
• 不可逆的電気穿孔法
• 凍結療法

腫瘍焼灼療法市場規模：治療別& CAGR（2025-2032）

• 市場概要
• 外科的アブレーション
• 経皮的アブレーション
• 腹腔鏡下アブレーション

腫瘍焼灼療法市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 肺がん
• 腎臓がん
• 肝臓がん

腫瘍焼灼療法市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院と診療所
• 専門センター

腫瘍焼灼療法市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Medtronic plc（Ireland）
• Boston Scientific Corporation（USA）
• Johnson & Johnson（USA）
• Abbott Laboratories（USA）
• Varian Medical Systems, Inc.（USA）
• Olympus Corporation（Japan）
• AngioDynamics, Inc.（USA）
• Terumo Corporation（Japan）
• Siemens Healthineers AG（Germany）
• Merit Medical Systems, Inc.（USA）
• EDAP TMS S.A.（France）
• Stryker Corporation（USA）
• Hologic, Inc.（USA）
• IceCure Medical Ltd.（Israel）
• Galil Medical, Inc.（USA）
• ConMed Corporation（USA）
• Neuwave Medical, Inc.（USA）
• SonaCare Medical LLC.（USA）
• Mermaid Medical A/S（Denmark）

結論と提言

Tumor Ablation Market size was valued at USD 1.9 billion in 2023 and is poised to grow from USD 2.17 billion in 2024 to USD 6.28 billion by 2032, growing at a CAGR of 14.2% during the forecast period (2025-2032).

The global rise in cancer incidence, coupled with a growing preference for minimally invasive treatment approaches, is poised to drive demand for tumor ablation techniques in the coming years. Innovations in ablation technologies are expected to unlock fresh opportunities for providers within this landscape. The increasing adoption of tumor ablation procedures in outpatient settings, along with the rising popularity of combination therapies, is likely to enhance product sales significantly. Additionally, the surging need for novel cancer treatments and bolstered investments in oncology research will further expand business potential. Emerging markets, particularly low to middle-income countries facing escalating cancer rates, present considerable opportunities. However, challenges such as the high costs of equipment, competition from conventional therapies, and limited awareness in developing regions may hinder long-term market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Tumor Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Tumor Ablation Market Segments Analysis

Global Tumor Ablation Market is segmented by Technology, Treatment, Application, End User and region. Based on Technology, the market is segmented into Radiofrequency, Microwave, Irreversible Electroporation and Cryoablation. Based on Treatment, the market is segmented into Surgical Ablation, Percutaneous Ablation and Laparoscopic Ablation. Based on Application, the market is segmented into Lung Cancer, Kidney Cancer and Liver Cancer. Based on End User, the market is segmented into Hospitals and Clinics and Specialty Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Tumor Ablation Market

The rising global prevalence of cancer is accelerating the demand for tumor ablation therapies, which are expected to play a crucial role in cancer management in the coming years. Tumor ablation offers a minimally invasive treatment option for various cancers, including those affecting the liver, lungs, and kidneys, making it particularly appealing for patients who are not suitable candidates for traditional surgical procedures. As the number of cancer cases continues to grow worldwide, the need for innovative and effective treatment solutions like tumor ablation is becoming increasingly important, highlighting its significance in the evolving landscape of oncological care.

Restraints in the Tumor Ablation Market

The tumor ablation market faces significant restraints primarily due to the high costs associated with the advanced technologies used in tumor ablation equipment. This steep pricing not only escalates the overall cost of treatment but also limits access for healthcare facilities with constrained budgets. As a result, the financial burden posed by such expensive equipment is a major factor hindering market growth and accessibility, presenting a notable challenge for providers looking to offer these innovative treatment options. Consequently, the high costs of tumor ablation products remain a critical constraint impacting the market outlook and expansion prospects.

Market Trends of the Tumor Ablation Market

The Tumor Ablation market is witnessing a significant trend towards the integration of advanced imaging guidance technologies, enhancing procedural accuracy and patient outcomes. Companies are increasingly adopting real-time imaging modalities such as MRI, CT, and ultrasound to improve the precision of ablation techniques, ultimately reducing complications and elevating success rates. This focus on imaging innovations not only streamlines the ablation procedures but also positions firms favorably in a competitive landscape where efficacy and safety are paramount. As healthcare providers seek to optimize treatment protocols, the demand for such technological advancements is expected to drive market growth in the coming years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Tumor Ablation Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Radiofrequency
• Microwave
• Irreversible Electroporation
• Cryoablation

Global Tumor Ablation Market Size by Treatment & CAGR (2025-2032)

• Market Overview
• Surgical Ablation
• Percutaneous Ablation
• Laparoscopic Ablation

Global Tumor Ablation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Lung Cancer
• Kidney Cancer
• Liver Cancer

Global Tumor Ablation Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Specialty Centers

Global Tumor Ablation Market Size & CAGR (2025-2032)

• North America (Technology, Treatment, Application, End User)
  • US
  • Canada
• Europe (Technology, Treatment, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Treatment, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Treatment, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Treatment, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EDAP TMS S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IceCure Medical Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galil Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ConMed Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuwave Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SonaCare Medical LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mermaid Medical A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations